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Abstract: The redox regulation of proteins via reversible dithiol/disulfide exchange reactions involves
the thioredoxin system, which is composed of a reductant, a thioredoxin reductase (TR), and
thioredoxin (Trx). In the pyridine nucleotide-dependent Trx reduction pathway, reducing equivalents,
typically from reduced nicotinamide adenine dinucleotide phosphate (NADPH), are transferred from
NADPH-TR (NTR) to Trx and, in turn, to target proteins, thus resulting in the reversible modification
of the structural and functional properties of the targets. NTR enzymes contain three functional sites:
an NADPH binding pocket, a non-covalently bound flavin cofactor, and a redox-active disulfide in
the form of CxxC. With the aim of increasing our knowledge of the thioredoxin system in archaea,
we here report the high-resolution crystal structure of NTR from the methane-generating organism
Methanosarcina mazei strain Gö1 (MmNTR) at 2.6 Å resolution. Based on the crystals presently
described, MmNTR assumes an overall fold that is nearly identical to the archetypal fold of authentic
NTRs; however, surprisingly, we observed no electron density for flavin adenine dinucleotide (FAD)
despite the well-defined and conserved FAD-binding cavity in the folded module. Remarkably,
the dimers of the apo-protein within the crystal were different from those observed by small angle
X-ray scattering (SAXS) for the holo-protein, suggesting that the binding of the flavin cofactor does
not require major protein structural rearrangements. Rather, binding results in the stabilization of
essential parts of the structure, such as those involved in dimer stabilization. Altogether, this structure
represents the example of an apo-form of an NTR that yields important insight into the effects of the
cofactor on protein folding.
Keywords: redox active site; thioredoxin; disulfide; flavin; NADPH; X-ray crystallography;
SAXS; methanoarchaea
1. Introduction
Thioredoxins (Trxs) participate in dithiol/disulfide exchange reactions that effect structural and
functional changes in target proteins via reversible change in the redox state of selected cysteine
(Cys) residues. Canonical members of the Trx family contain the common amino acid sequence
motif WCGPC in the active site with two strictly conserved Cys that target proteins capable of
reversibly forming a disulfide bridge. The Cys are reduced to the sulfhydryl form by a Trx reductase
(TR) [1]. In many cases, TRs are dependent on reduced nicotinamide adenine dinucleotide phosphate
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(NADPH) (NADPH-dependent TR or NTR). Based on phylogenetics, protein structure, and molecular
mechanism, two groups of NTRs are recognized: (i) Bacteria, plants, lower eukaryotes, and archaea
contain low-molecular weight (LMW)-NTRs of about 35 kDa with a non-covalently bound flavin
adenine dinucleotide (FAD) cofactor. These enzymes accept reducing equivalents from NADPH and
transfer them to a redox-active disulfide motif (CxxC) that subsequently reduces Trx to its sulfhydryl
form in a dithiol–disulfide exchange reaction. These transfer reactions involve a large conformational
rearrangement within the enzyme [2]; (ii) High-molecular-weight (HMW)-NTRs are enzymes of about
55 kDa present in eukaryotes that have developed an alternate mechanism for the transfer of reducing
equivalents to Trx. Also homodimers with a non-covalently bound FAD, these enzymes are fitted
with a third redox-active motif that contains either a Cys or selenocysteine at a mobile C-terminal tail.
They have the capacity to transfer reducing equivalents from the CxxC motif to the disulfide in Trx [3].
The structural dynamics and functional mechanisms of NTRs have been extensively studied in
bacteria and eukaryotes. In archaea, functional studies of the Trx system are available for several
species, including Aeropyrum pernix [4], Pyrococcus horikoshii [5], Methanosarcina acetivorans [6,7], and
Sulfolobus solfataricus [8]. The archaeal NADPH-linked Trx system is biochemically similar to that of
bacteria. However, dissimilarities were detected in Methanocaldococcus jannaschii [9] and Thermoplasma
acidophilum [10], where the thioredoxin system (TS) functions independently of NADPH. Here, the
coenzyme F420 provides reducing equivalents for M. jannaschii TR (MjTR). T. acidophilum TR (TaTR),
by contrast, is linked to NADH pyridine [10,11].
The present study was conducted (i) to apply in silico analysis for identifying members of the
TS in the mesophilic Methanosarcina mazei, and (ii) to determine the X-ray crystal structure of its NTR.
M. mazei is an anaerobic ecologically important methanoarchaeon with a broad substrate spectrum,
able to generate methane using H2 and CO2, methanol, or methylamines as well as acetate as an energy
and a carbon source [12,13]. It represents a model organism for the methanoarchaea.
2. Materials and Methods
2.1. MmNTR Protein Production and Purification
The full-length NTR of M. mazei strain Gö1 (MM2353) was cloned into pET28a, resulting in a
cleavable N-terminal 6xHis-tagged fusion protein. Protein was produced in BL21pRIL Escherichia coli
cells upon induction with 0.2 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) at 22 ◦C. Cells were
disrupted by sonication in 20 mM Tris-HCl buffer, pH 7.6, containing 300 mM NaCl, 10% glycerol, and
1 mM phenylmethylsulfonyl fluoride. The crude extract was clarified by centrifugation at 40,000× g for
1 h. The enzyme was purified using nickel-nitriloacetic acid (Ni-NTA) chromatography (GE Healthcare)
and digested with thrombin (EMD Chemicals, San Diego, CA, USA) in buffer, 20 mM Tris-HCl pH
8, 150 mM NaCl, and 2 mM CaCl2, at room temperature overnight. The last step of purification
involved gel filtration chromatography (Sephacryl S-300) using 10 mM Tris-HCl pH 7.6, 100 mM
NaCl, and 2 mM 2-mercaptoethanol buffer. For protein molecular weight estimation by size exclusion
chromatography, the column was calibrated with the Gel Filtration Standard mixture from Bio-Rad.
2.2. Protein Crystallization, Data Collection, and Structure Solution
One microliter of a 15 mg/mL protein solution in buffer, 10 mM Tris-HCl pH 8 and 50 mM NaCl,
was mixed with 1 µL of a solution containing 0.1 M sodium acetate, pH 4.8, and 1 M ammonium
chloride. Protein crystals appeared after 4 days of incubation at 25 ◦C on a sitting drop crystallization
plate. Crystals were transferred to a solution containing Paratone Oil before flash freezing. Diffraction
data were collected at a wavelength of 1 Å on the X06DA beamline of the Swiss Light Source
synchrotron (SLS, Villigen, Switzerland). The diffraction data were processed and scaled using XDS
and XSCALE programs [14]. The MmNTR structure was determined using an approach integrating
molecular replacement using Phaser [15] and automated model building. Initially, a homology model
of the NADPH-binding domain was used as search tool. The template was generated by FFAS03
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server [16] based on the thioredoxin reductase structure of Thermoplasma acidophilum (Protein Data
Bank (PDB) code 3CTY) [10], freed of non-conserved loops and side chains. Phenix.autobuild [17]
was then used for automated model building of the FAD-binding domain. The final structure was
refined using the Phenix crystallographic software suite [17], alternating with visual inspection of the
electron density maps and manual modeling with Coot [18]. Data collection and refinement statistics
are summarized in Table S1. The structures were rendered using Pymol [19]. Atomic coordinates and
crystallographic structure factors have been deposited in the PDB under the accession code 4ZN0.
2.3. SAXS
SAXS data were collected at the B21 beamline at the Diamond Light Source using an online
SEC-HPLC system coupled SAXS setup. In line SEC-SAXS was performed using an Agilent 1200
HPLC system equipped with a 2.4 mL Superdex 200 (GE Healthcare Life Sciences, Amersham, UK)
column. Forty-five microliters of a protein sample at 5 mg/mL were loaded onto the size exclusion
column equilibrated in 20 mM Tris-HCl pH 7.6, 150 mM NaCl, and 2 mM DTT. Data were collected
all along the chromatogram at 3 s per frame, and recorded on a Pilatus 2M detector with a fixed
camera length of 4.014 m, covering a scattering vector (q) range from 0.0032 to 0.38 Å−1. The X-ray
wavelength was set at 1.0 Å, equivalent to 12.4 keV. The scattering data were analyzed using the
programs Chromixs [20] and Crysol [21] of the ATSAS package [22].
2.4. The Protein Sequence Analysis and Structure Modeling
Homolog protein sequences were retrieved from the National Center for Biotechnology
Information’s database using the Blastp program [23]. Protein multiple sequence alignments were
performed with ClustalX [24]. Structural homology models were generated using Phyre2 [25] using
SaNTR (PDB code 4GCM) as a template (100% confidence, 45% identity; 99% coverage).
3. Results
3.1. Description of the M. Mazei Trx System
The sequence analysis of the genome of M. mazei Gö1 revealed an open-reading frame (Locus tag
MM_RS12200) that encoded a protein annotated as NADPH-dependent thioredoxin reductase
(MmNTR). The amino acid sequence of the NTR-translated gene contained linear motifs for the binding
of FAD (GGGPAG) and NADPH (GGGNSA and HRRDHLK) and a CxxC redox motif (Figure 1A),
which are typically observed in NTRs [26]. A Blast search [23] of the non-redundant protein database
using the MmNTR sequence as input revealed closest amino acid sequence similarity to low-molecular
weight NTRs (Figure 1A). A comparison with the NTR enzyme from M. acetivorans C2A NTR (MaNTR)
showed 83% identity and 92% similarity at the protein sequence level. Two other archaeal TR proteins
have been included in the sequence analysis as they are of interest: the TR of M. jannaschii (MjTR)
that employs F420 as an electron donor [9], and the TR of T. acidophilum (TaTR), which was initially
described as a pyridine nucleotide-independent TR [10] and has recently been shown to display activity
with NADH (but not NADPH) as an electron donor [11]. The MjTR and TaTR sequences lack the
motifs necessary for NADPH coordination (the HRRxxxR motif in Figure 1A). Thereby, according to
the protein sequence comparison, MmNTR is classified as a canonical LMW-NTR.
Thioredoxins are described as proteins of about 88 amino acids with the canonical motif
WCGPC [27]. Using EcTrx as input in Blast homology searches [23], it was found that M. mazei
contains two Trxs, herein named MmTrx1 (MM_RS02345) and MmTrx2 (MM_RS05160) (Table 1 and
Figure 1B). MmTrx1 has a shorter sequence than canonical Trxs at its N-terminus, and its functional
annotation awaits further investigations. The MmTrx2 amino acid sequence contains several insertions
that provide the protein with additional structural elements compared to EcTrx; like the M. acetivorans
homolog [6] (Table 1), the MmTrx2 gene is located upstream of the gene encoding the membranous
CcdA oxidoreductase [28], suggesting a functional relation.
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Methanosarcina mazei NTR (MmNTR), Methanosarcina acetivorans NTR (MaNTR), Staphylococcus aureus 
NTR (SaNTR), Sulfolobus solfataricus NTR (SsNTR), Methanocaldococcus jannaschii TR (MjTR), 
Thermoplasma acidophilum TR (TaTR), Escherichia coli NTR (EcNTR); and, (B) E. coli Trx (EcTrx), and 
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Figure 1. Protein multiple sequence alignment of selected NADPH-dependent Trx reductase (NTR) (A)
and Trx (B). The positions of the conserved residues involved in FAD- and NADPH-binding are marked
in panel (A) in black and blue, respectively; the region implicated in FAD coordination is depicted
in red (see also Figure 3A below). The CxxC redox-active site motifs are shown in green in (A,B).
Asterisks and column colors are assigned according to the ClustalX program’s standard parameters.
The ruler below indicates the amino acid position in the alignment. On the right, the number of amino
acids for each Trx is stated. The figure includes the amino acid sequences from (A) Methanosarcina mazei
NTR (MmNTR), Methanosarcina acetivorans NTR (MaNTR), Staphylococcus aureus NTR (SaNTR),
Sulfolobus solfataricus NTR (SsNTR), Methanocaldococcus jannaschii TR (MjTR), Thermoplasma acidophilum
TR (TaTR), Escherichia coli NTR (EcNTR); and, (B) E. coli Trx (EcTrx), and five Trx sequences from
M. mazei (MmTrx1–MmTrx5).
Table 1. The thioredoxin system composition in M. mazei and a comparison with the M. acetivorans system.
M. Mazei
Trx Gene ID Catalytic Motif
M. Acetivorans
Homolog [6] Reductant
Reduction of
Insulin [7]
MmTrx1 MM_RS02345 WCGPC MaTrx2 unknown +
MmTrx2 MM_RS05160 WCGPC MaTrx6 unknown +
MmTrx3 MM_RS12205 WCTAC MaTrx7 NTR [6] +
MmTrx4 MM_RS11655 GCPKC MaTrx5 unknown -
MmTrx5 MM_RS10780 ACPYC MaTrx1 FDR [29] -
NTR, NADPH-thioredoxin reductase; FDR, ferredoxin:disulfide reductase.
A sequence analysis of the M. mazei Gö1 genome also identified atypical Trxs with varying
active sites. NTR was placed adjacent to the gene MM_RS12205 that encoded a predicted Trx protein,
herein called MmTrx3, with a WCTAC redox motif (Table 1 and Figure 1B); MmTrx3 is a homolog
of Trx7 from M. acetivorans (MaTrx7) that has been biochemically demonstrated to be reduced by an
NTR [6]. Other atypical Trxs include MM_RS11655 (MmTrx4) and MM_RS10780 (MmTrx5) with the
non-canonical catalytic motifs GCPKC and ACPYC (Table 1 and Figure 1B). Their respective homologs
in M. acetivorans ( aTrx5 and MaTrx1) failed to display insulin disulfide reductase activity and are
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of unknown function [7]. Recently, a ferredoxin:disulfide reductase (FDR) has been demonstrated
to reduce MaTrx5 [29]. FDRs are Fe-S enzymes present in a number of archaea and bacteria that are
related to the plant-type ferredoxin:thioredoxin reductase catalytic subunit (FTRc) [30]. Apparently,
the NTR and FDR systems are both functional in Methanosarcina [29,31,32].
3.2. Purification and Structural Features of MmNTR
According to the protein sequence, MmNTR has a theoretical molecular weight of 35 kDa.
A homogenous sample of MmNTR protein was prepared using the protocol described in the Materials
and Methods section. The purified MmNTR migrated as a single band with an apparent molecular
mass of 35 kDa in sodium dodecyl sulfate-polyacrilamide gel electrophoresis (SDS-PAGE) (Figure 2A).
The purified MmNTR eluted as a single peak during gel filtration chromatography. The deduced
molecular mass of 70 kDa indicates that MmNTR is a homodimer in solution (Figure 2B). The protein
displayed a yellow color, and showed an absorption spectrum typical of a flavoprotein with peaks at
about 274, 388, and 456 nm (Figure 2C).
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Figure 2. MmNTR was heterologously expressed in E. coli, and purified by affinity and size exclusion
chromatography. (A) A Coomasie-stained SDS-PAGE image of purified MmNTR. The molecular
weight markers are indicated on the left (100, 75, 50, 37, 25, 20, 15, and 10 kDa); (B) The size exclusion
chromatography (Sephacryl S300) elution profile for MmNTR; (C) The UV-visible absorption spectrum
of MmNTR in buffer, 10 mM Tris-HCl pH 7.6, 100 mM NaCl, and 2 mM 2-mercaptoethanol.
3.3. Apo-MmNTR is a Homodimer Composed of Two Domains
Protein crystals of M NTR were obtained, and the X-ray structure was solved and refined
to a resolution of 2.6 Å (Table S1). The X-ray structure shows that MmNTR is a homodimer, in
agreement with the gel filtration data, with a structural organization that is analogous to other
LMW-NTRs. Monomers consist of two Rossmann-fold domains that functionally correspond to
FAD- and NADPH-binding domains [33] (Figure 3A). The FAD-binding domain is formed by two
discontinuous segments of the polypeptide chain (residues 1–111 and 245–307 in MmNTR), and adopts
a three-layer β/β/α-fold with a central four-stranded β-sheet flanked by a three-stranded β-sheet and
three parallel α-helices. The NADPH-binding domain (residues 116–240) consists of a four-stranded
β-sheet with three parallel α-helices and a three-stranded β-sheet at its flanks. The NADPH-binding
domain is inserted into the FAD-binding domain via two antiparallel strands, β-7 (residues 112–114)
and β-15 (residues 242–244) (Figure 3A). The redox motif CxxC (residues 132–136) is located on helix-
α3 within the NADPH domain, with the two Cys forming a disulfide bridge in the crystal (Figure 3A).
Remarkably, no electron density of FAD or any other molecule was found at the presumed
cofactor-binding pocket. The MmNTR structure thus represents the apo-form of the flavoprotein.
Attempts to obtain crystals of the FAD-containing enzyme, including the addition of FAD to the
crystallization drop, were unsuccessful. A search of structural homologues of the FAD domain of
MmNTR using the Dali server [34] revealed that it is highly similar to the FAD-binding domains of
other NTRs despite the absence of the cofactor. The FAD domain of MmNTR superimposes to the
FAD domain of NTR from Staphylococcus aureus (SaNTR; PDB code 4GCM) with a root mean square
deviation value of 1.7 Å (Figure 3B). The largest structural variations were found in a region next to
Antioxidants 2018, 7, 166 6 of 11
the FAD-binding pocket, the so-called FAD-loop, which encompasses residues Ile37 through Pro55
(Figure 3B, in red), that lacks a defined electron density in the apo-structure and is, therefore, omitted
from the final MmNTR model. The region constitutes a loop and a 3(10)-helix that covers the FAD
isoalloxazine ring on its si-face, and a loop involved in dimerization [33]. Because the majority of
FAD-contacting residues are strictly conserved in MmNTR (Figure 1A), a similar FAD binding mode is
anticipated for this enzyme.
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Figure 3. The crystal structure of MmNTR shown in a cartoon representation. (A) Monomers of
MmNTR homodimers fold into two domains: The FAD-binding domain and the NADPH-binding
domain. The Cys of the CxxC motif at the NADPH-binding domain are shown in sticks. The two
domains are connected by two beta-strands (β-7 and β-15) that facilitate the conformational flexibility
of the molecule. The redox-active disulfide faces inwards, where it would be accessible to reduction
by the flavin, and the NADPH-binding site exposed to the solvent. The missing parts of the final
model are indicated by dotted lines. (B,C) Fold comparison of FAD- and NADPH-binding domains,
respectively, of MmNTR (in blue) and SaNTR (PDB code 4GCM, in brown). No electron density of FAD
was found at the expected cofactor-binding pocket in MmNTR, despite the well-defined and conserved
FAD-binding cavity in the folded module. The FAD from SaNTR is drawn as sticks. The FAD-loop and
NADPH-binding motif are colored in red.
The NADPH-binding domain has no detectable pyridine nucleotide in the crystal structure, but
displays essentially the same fold as the equivalent domain in SaNTR (Figure 3C). The binding site of
the pyridine nucleotides in SaNTR includes a turn in a region containing conserved glycine amino
acids (Gly152–154; Figure 3C, in red), and is dominated by electrostatic interactions between the
cofactor phosphates and a cluster of arginine residues (motif HRRxxxR in Figure 1A). The lining of the
residues is similar, implying that the cofactor-binding sites of both enzymes are comparable.
3.4. Apo-MmNTR Monomers Adopt a Flavin-Oxidizing Conformation
The NADPH-binding domain is positioned in an orientation with respect to the FAD-binding
domain that exposes the NADPH-binding site to the bulk solvent and approaches the CxxC motif over
the re-face of the isoalloxazine ring of the presumed flavin cofactor. This arrangement corresponds
to the flavin-oxidizing (FO) conformation of NTRs that allows for the interaction of the disulfide
bridge of the CxxC motif with the isoalloxazine ring of the flavin in a conformation competent for
the reduction of the disulfide [35]. The two antiparallel beta-strands connecting the two domains
are conserved (Figure 3A), and motion of the NADPH-binding domain relative to the FAD-binding
domain is anticipated, as it required for the functional activity of the enzyme during the catalytic cycle.
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3.5. The Absence of the Flavin Cofactor Compromises Dimer Formation
A structural comparison of MmNTR with Escherichia coli (EcNTR) homodimers reveals a
significant difference at the dimer interface (Figure 4). In EcNTR, two-thirds of the dimer interface is
formed by interactions between the FAD-binding domains that involve primarily three α-helices and
two loops [36]. By contrast, the FAD-binding domains slide up to the dimer interface of MmNTR with
the consequent loss of α-helix contacts. This results in new interactions between the NADPH-binding
domain of one monomer with the FAD-binding domain of the opposite monomer (Figure 4 and
Figure S1). Subsequently, the two domains in MmNTR are differently positioned each to the other
with respect to canonical NTRs. This modification is likely a consequence of the loss of FAD, which
results in the structural destabilization of the region comprising residues 36 to 68 that disrupts the
dimer interface.
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Figure 4. A structural comparison of the homodimer interface in (A) MmNTR, with the FAD- and
NADPH-binding domains in blue and yellow, respectively; and (B) EcNTR (PDB code 1TRB), with the
FAD- and NADPH-binding domains in magenta and orange, respectively. The interaction between
two monomers within the crystal lattice buries 1696.9 Å2 in MmNTR versus 2735.2 Å2 in EcNTR of
protein surface.
3.6. SAXS Reveals a Typical LMW-NTR Conformation of MmNTR
We further analyzed the structure of the enzyme using Size-Exclusion Chromatography coupled
to with Small Angle X-ray Scattering (SEC-SAXS). As shown in Figure 5, the simulated scattering
curve of the crystal structure fits the experimental SAXS data poorly (the curve was computed by
Crysol [21]). These discrepancies indicate that the structure of MmNTR in solution differs significantly
from the crystal model. Based on these results, a three-dimensional homology model for MmNTR was
generated with the modeling server Phyre2 [25] using the crystal structure of SaNTR as a template.
The theoretical scattering profiles calculated from the model fit the experimental SAXS curve quite well
(Figure 5), and confirm that MmNTR, when bound to FAD, acquires an archetypal FO conformation
in solution. These data confirm that MmNTR dimers in solution acquire the same structure as
canonical LMW-NTRs.
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4. Discussion
A genome-wide sequence analysis showed that the composition of the Trx system of M. mazei Gö1
is similar to that of other Methanosarcina [7], with two Trxs having the canonical WCGPC redox-active
motif as well as two Trx-related proteins of diverse features. Two different thiol reductases, NTR and
FDR, have been shown to function in the reduction of Trxs in M. acetivorans, but not of canonical Trxs.
This suggests the presence of other reduction pathways in this type of archaea. The elucidation of
alternative reduction systems requires further work; possibilities might include the Fe-S proteins that
have been detected in the genomes of Methanosarcina, including those that have been related to the
catalytic subunit of the FTR protein that is functional in plants [30].
The high-resolution structural analyses of various bacterial NTRs show that LMW-NTRs are
homodimers with two Rossmann-fold domains in each subunit [33]. One domain is responsible for
FAD coordination (the FAD-binding domain); a second domain carries the CxxC redox-active motif
and interacts with NADPH for transferring the reducing equivalents (the NADPH-binding domain).
The two domains are joined by two antiparallel beta-strands that coordinate the spatial movement
of one domain relative to the other during the catalytic cycle, in the so-called flavin-oxidizing (FO)
and flavin-reducing (FR) conformations [35]. The crystal structure obtained in this work shows
that MmNTR is a homodimer with two domains per monomer. Despite the lack of a cofactor,
MmNTR has a canonical NTR fold. Further, the absence of the flavin results in a locally disordered
conformation in a region of the protein that compromises dimer association, thus resulting in abnormal
monomer–monomer interactions.
The protein was crystallized in the FO conformation, with the CxxC motif forming a disulfide
bridge placed over the isoalloxazine ring of the assumed FAD. It is anticipated that MmNTR undergoes
a general rearrangement that leads to interdomain motion to permit the transfer of reducing equivalents
from NADPH to CxxC, and subsequently to Trx.
Our attempts to solve the holo-structure by X-ray crystallography have not been successful so
far due to loss of the flavin cofactor during crystallization. Therefore, we performed SAXS studies
to obtain structural information on the MmNTR holo-protein, concluding that the conformation of
MmNTR in solution is similar to canonical LMW-NTR proteins. The differences between the crystal
and the SAXS MmNTR structures might be attributed to the loss of the flavin cofactor, likely during
the crystallization process.
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5. Conclusions
We have presented a description of the thioredoxin system of M. mazei Gö1 and the structure
of apo-MmNTR obtained by X-ray crystallography and SAXS. Our results show that the structural
features of the LMW-NTR family of proteins are well-conserved in the MmNTR structure. The results
suggest a primary important role of FAD. The cofactor, which may have been lost during crystallization,
appears to function in protein folding since its absence impacts the ability of the enzyme to form the
physiological dimer interface. In future work, the three-dimensional structure of the holo-form of the
enzyme should provide more accurate data on the conformational organization of the redox-active sites.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/7/11/166/
s1, Table S1: Data collection and refinement statistics, Figure S1: Interaction between monomers in MmNTR.
The interface is stabilized by hydrophobic interactions, mostly between the side chain of aromatic residues,
including Tyr22, Tyr26, Phe161, Tyr301, and Trp264, among others. Hydrogen bonds have also formed between
the side chain of the residue Arg142 and the main chain of the residue Arg25, the side chain of Try22 and the main
chain of Ile135, as well as a salt bridge between the side chains of the residues Lys164 and Glu302.
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